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Background: Gene targeting is a powerful method that can be used for examining the functions of genes.
Traditionally, the construction of knockout (KO) vectors requires an amplification step to obtain two homologous,
large fragments of genomic DNA. Restriction enzymes that cut at unique recognitions sites and numerous cloning
steps are then carried out; this is often a time-consuming and frustrating process.
Results: We have developed a one-step cloning method for the insertion of two arms into a KO vector using
exonuclease III. We modified an adeno-associated virus KO shuttle vector (pTK-LoxP-NEO-AAV) to yield pAAV-LIC,
which contained two cassettes at the two multiple-cloning sites. The vector was digested with EcoRV to give two
fragments. The two homologous arms, which had an overlap of 16 bases with the ends of the vector fragments,
were amplified by polymerase chain reaction. After purification, the four fragments were mixed and treated with
exonuclease III, then transformed into Escherichia coli to obtain the desired clones. Using this method, we
constructed SirT1 and HDAC2 KO vectors, which were used to establish SirT1 KO cells from the colorectal cancer
cell line (HCT116) and HDAC2 KO cells from the colorectal cancer cell line (DLD1).
Conclusions: Our method is a fast, simple, and efficient technique for cloning, and has great potential for
high-throughput construction of KO vectors.Background
Gene targeting is a powerful method for the production
of genetically modified cell lines or animals, allowing for
the various functions of genes to be studied. In mice,
several thousand genes have been disrupted using hom-
ologous recombination. However, when these methods
have been applied to human somatic cells they have gen-
erally been ineffective because of very low targeting effi-
ciencies [1]. Although RNA interference can reduce the
expression of a gene, interpretation of such experiments
can be unreliable because of non-specific targeting or in-
complete inactivation of genes. Therefore, we believe it
is essential to improve the efficiency of knockout (KO)
approaches in human somatic cells.
Recombinant adeno-associated viruses (rAAVs), such
as human parvovirus, possess a single-stranded DNA
genome of around 4.7 kb. Hirata [2] and Porteus [3]* Correspondence: runleidu@whu.edu.cn
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reproduction in any medium, provided the orfound that rAAVs can be used to target genes in human
cell lines. Use of these rAAVs resulted in higher target-
ing frequencies than those obtained with conventional
plasmid vectors [4,5]. The wild-type human parvovirus
genome contains two open reading frames (ORFs),
designated rep and cap, flanked by two inverted terminal
repeats. The rep ORF encodes proteins involved in viral
replication, and the cap ORF encodes proteins necessary
for viral packaging. In rAAV-mediated KO vectors these
ORFs are deleted and replaced with a neomycin resistant
gene flanked by two homology arms. The stages involved
in carrying out rAAV-mediated gene KO include: (i) de-
sign and construction of the AAV KO vector; (ii) collect-
ing an infectious rAAV stock; (iii) infecting the
appropriate cell line; (iv) screening for homologous
recombinants; and (v) iteratively targeting the multiple
alleles. It takes at least three months just to target the
first allele [6].
Apart from the low efficiency of homologous recom-
bination, a rate-limiting step in gene targeting of humanThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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struct. Traditionally, this requires an amplification step
to obtain two large homologous fragments of genomic
DNA, followed by restriction endonuclease digestion,
and then numerous cloning steps. It is an extremely
time-consuming process and limited by the available
unique restriction enzyme sites in the vector and in the
two amplified homologous fragments. Phage-based
Escherichia coli homologous recombination systems
[7-9] have been developed that now make it possible to
subclone or modify DNA cloned into plasmids, bacterial
artificial chromosomes (BACs), or P1-derived artificial
chromosomes (PACs) without the need for restriction
enzymes or DNA ligases. However, these recombination
systems require long homology arms and usually one can
only insert one fragment at the time.
Traditional DNA cloning suffers from several limita-
tions, including poor ligation efficiency, along with a de-
pendence on the availability of unique restriction sites in
both the insert and vector. For this reason, many meth-
ods regarding directional subcloning have been devel-
oped [10,11]. These methods include the use of uracil
DNA N-glycosylase [12], T4 DNA polymerase [13], en-
zymatic assembly [14-16] or exonuclease III (ExoIII) [17]
to generate long compatible cohesive ends between the
DNA insert and cloning vector. It has also been found
that by generating longer cohesive ends, the annealed
DNA complex becomes more stable and the ligation re-
action can be omitted. This technique has come to be
known as ligation-independent cloning (LIC), and has
been demonstrated to have a high efficiency. Developing
more LIC methods will give the researchers more chioce
according to the different situations.
To increase cloning efficiency and ligation of four frag-
ments simultaneously, we developed a one-step LIC
method for construction of KO vectors. Using this
method, it becomes easy to construct KO vectors in two
days. In this paper, we have outlined our strategy for
modifying pTK-LoxP-NEO-AAV, and demonstrated suc-
cessful construction of a SirT1 and HDAC2 KO vector.
Once we had made the vectors, we were able to obtain
SirT1 KO cells from the colorectal cancer cell line
HCT116 and HDAC2 KO cells from the colorectal can-
cer cell line DLD1.
Results and discussion
Construction and characterization of a pAAV-LIC vector
Assembly of gene-targeting constructs is a rate-limiting
step when targeting genes in human somatic cell lines.
Other limitations include multi-step ligations and the
availability of unique restriction sites in the insert and
vector. To overcome many of these limitations we modi-
fied an AAV shuttle vector into a one-step LIC vector.
This was achieved by introducing two fixed cassettesinto the multiple-cloning site (MCS) of the shuttle vec-
tor (Figure 1). The two cassettes involved three ele-
ments: sticky ends complementary to the cloning site in
pTK-LoxP-NEO-AAV, allowing for insertion of the cas-
settes; EcoRV sites in the middle of the cassette, which
could be used to cut the LIC vector into two fragments
containing blunt ends; and 14- to 18-mer sequences that
could produce long sticky ends when ExoIII was used.
First, cassette A was inserted into pTK-LoxP-NEO-AAV
using EcoRV and SalI digestion. Because the cassette
end did not include the EcoRV palindromic sequence,
this process restored the SalI site and destroyed the ori-
ginal EcoRV site. Following confirmation by sequencing,
cassette B was inserted into the vector now containing
cassette A. This was facilitated by digestion with NheI
and SpeI digestion. The modifications to the vector were
again confirmed by sequencing, and we designated the
designed vector as pAAV-LIC.
Construction of a SirT1 and HDAC2 KO vectors
We used pAAV-LIC to construct SirT1 and HDAC2 KO
vector by one-step LIC (Figure 2). The pAAV-LIC vector
was digested with EcoRV, resulting in two fragments (ap-
proximately 1 kb and 3.1 kb). These fragments were
recovered from agarose gels following electrophoresis
and purified using gel extraction kits. The smaller frag-
ment was found to contain the thymidine kinase (TK)
promoter, the LoxP sequence and the neomycin ORF.
The larger fragment was found to contain the AAV
backbone, necessary for plasmid replication in E. coli,
and for viral packaging.
The two homologous arms for SirT1 and HDAC2 KO
vector construction were obtained by polymerase chain
reaction (PCR) and purified using gel extraction kits.
The PCR primers used were designed to add additional
14- to 18-mer sequences overlapping with the ends of
digested vector fragments. Polymerases, including Taq
polymerase, possess the ability to add dATP at the 30
ends of PCR products, thereby inhibiting the 30 exo-
nuclease activity of ExoIII. Therefore we recommend
using pfu or PrimeStar polymerases when amplifying
homologous arms, as they result in amplicons with blunt
ends.
The 30 exonuclease activity of ExoIII is very high at
37°C. To generate 16-mer overhangs at a stable and low
rate, it is necessary to optimize reaction temperature
and time. According to our experience, to ensure stable
cloning, 1 h at 0°C or 30 min at 4°C are both sufficient.
Using other conditions proved difficult, with both the
number of colonies and the rate of positive transfor-
mants acquired highly variable. To produce complemen-
tary sticky ends, the purified homologous arms and two
vector fragments were mixed and chilled at 0°C for 10
min, then treated with 20 U of ExoIII at 0°C for 1 h. The
Figure 1 Schematic depicting the modification of pTK-LoxP-NEO-AAV into pAAV-LIC by insertion of two designed LIC adaptors. The
two LIC adaptors contain EcoRV sites and an additional 11–15 bp sequence necessary for LIC cloning. The two EcoRV restriction sequences are
underlined and an arrow indicates the digestion sites. Left blunt end and right overhang sequences for EcoRV and SalI in cassette A allow for
annealing of the LIC adaptor into the right arm MCS of the pTK-LoxP-NEO-AAV plasmid. Overhang sequences for NheI and SpeI in cassette B
allow for annealing of the LIC adaptor into the left arm MCS.
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65°C. After transformation into DH5α E. coli, enzymatic
bacterial DNA repair machinery helped to facilitate
ligation endogenously.
Colony PCR and sequencing was used to verify the
positive transformants. Screening by PCR showed that 9
of the 12 colonies analyzed were positive transformants
(Figure 3a). Sequencing results further confirmed the
PCR results (Figure 3b and c). The resulting KO vector
was designated as the AAV-SirT1 KO vector. Also we
got the AAV-HDAC2 KO vector.
Use of gene targeting to generate SirT1-null HCT116 cells
and HDAC2-null DLD1 cells
To confirm its ability to be used in the development of
KO cell lines, the targeting AAVs were packaged in
293T cells by transfecting equal amounts of the SirT1
KO targeting vector targeting vector, pHelper and pRC.
Then HCT116 cells were infected with the SirT1 target-
ing viruses and selected with geneticin. After two weeks,
the neomycin-resistant clones were screened for hom-
ologous recombination by genomic PCR. We screened
100 clones and obtained 4 positives. To remove the
neomycin-resistant gene, two of the correctly targeted
clones were infected with adenoviruses expressing Cre-
recombinase. Using genomic PCR, we screened 24clones, with 10 of them found to be positives containing
an additional 250 bp fragment in which the LoxP site
was inserted. Up until this point we had succeeded in
obtaining heterozygous KO clones. To delete both
alleles, heterozygous KO clones were infected with the
same targeting virus and the neomycin resistance gene
was excised. Finally we obtained homozygous KO clones
and the KO cell lines were confirmed by western blot
(Figure 4a). Use the same protocol, HDAC2 targeting
viruses were made and DLD1 cells were infected with
the HDAC2 targeting viruses. Also we obtained
HDAC2-null DLD1 cells and confirmed by western blot
(Figure 4b).
Conclusions
As outlined above, we successfully constructed the AAV-
SirT1 and AAV-HDAC2 KO vectors and obtained SirT1
and HDAC2 KO cell lines. Compared with the trad-
itional ‘digestion-ligation’ vector construction method,
our approach is not limited by the availability of restric-
tion sites; therefore, somatic cell gene KO vectors can be
easily constructed within 2–3 days. Additionally, our
method does not require the use of any single specific
restriction enzyme, and has great potential for the
high-throughput construction of gene KO vectors. How-
ever, it also has some limitations, such as the potential
Figure 2 Construction of a somatic cell KO vector via a one-step cloning method. Cassette A is indicated by two rectangles and cassette B
by two echelons. The homologous arms were amplified using PCR with primers containing the 15–18 nt sequence at the 50 end and sequences
specific for the ExoIII-generated overhangs in pAAV-LIC. E2–6: exons 2–6; NEO: neomycin resistance gene; TK: thymidine kinase promoter.
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and it need high efficiency competent cells for the
transformation.
Methods
Materials and bacterial strains
Restriction enzymes, Pfu polymerase, ExoIII and DNA
ligation kits were purchased from Takara (Dalian,
China). Kits for plasmid minipreps, DNA purification
and genome extraction were purchased from Tiangen(Beijing, China). Primers were purchased from Genscript
(Nanjing, China). The E. coli DH5α strain was used for
plasmid preparation and all restriction-based cloning.
Cell culture
HEK-293T cells were cultured in Dulbecco’s modified
Eagle’s medium (DMEM) containing 10% fetal bovine
serum (FBS) and 100 units/ml penicillin-streptomycin.
The colorectal cancer cell line, HCT116, was cultured in
McCoy’s 5A containing 10% FBS and 100 units/ml
Figure 3 Colony PCR and sequencing results for the pAAV-SirT1 gene KO plasmid. (a) Colony screening by PCR. Left arm (> 1 kb) and right
arm (< 1 kb) positives are shown. (b) The sequence in the joint formed by the vector and the left arm of SirT1. The joint sequence is underlined
in gray. (c) The sequence in the joint formed by the vector and the right arm of SirT1. The joint sequence is underlined in gray.
Figure 4 KO cell lines were confirmed by western blot. (a)
Western blots of wild-type, heterozygous and homozygous SirT1 KO
cell lines from HCT116 cells using anti-SirT1 and anti-β-actin
antibodies. WT indicates parental cells, WT/KO indicates SirT1
heterozygous KO cells, KO/KO indicates SirT1 homozygous KO cells.
(b) Western blots of wild-type and homozygous HDAC2 KO cell lines
from DLD1 cells using anti-HDAC2 and anti-β-actin antibodies. WT
indicates parental cells, WT/KO indicates HDAC2 heterozygous KO
cells, KO/KO indicates HDAC2 homozygous KO cells.
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chased from AppliChem (Seajet Scientific Co., Ltd.,
Beijing, CHINA). All other cell culture reagents were
obtained from Life Technologies Corporation (Shanghai,
CHINA).
Construction of the modified AAV shuttle vector
The AAV shuttle vector, pTK-LoxP-NEO-AAV, was
modified to produce the pAAV-LIC vector. Two pairs of
unique primers were designed for creating ‘LIC zones’.
These primer pairs were cassette A (sense, 50-CAT GGG
TGG TGG GAT ATC TTA TAC TTC CAA G-30; and
antisense, 50-TCG ACT TGG AAG TAT AAG ATA TCC
CAC CAC CCA TG-30) and cassette B (sense, 50-CTA
GCA TGG TGA GAA TTT ATG ATA TCC CCA CCC
TCC CAG A-30; and antisense, 50-CTA GTC TGG GAG
GGT GGG GAT ATC ATA AAT TCT CAC CAT G-30).
The underlined sequence indicates the recognition site
for EcoRV.
Primers were diluted to 5 mM with double-distilled
water. Sense and antisense primers (3 μl of each) for cas-
sette A or cassette B were mixed with 3 μl of buffer 3
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bated at 94°C for 10 min, then cooled slowly to room
temperature. Cassette A or B fusion products were
inserted into the digested pTK-LoxP-NEO-AAV vector
using DNA ligation kits. Recombinants were verified by
restriction analysis and sequencing.
General primers for AAV gene-targeting vectors
The homologous arm is around 1 kb, and we designed
primers using primer3 (http://frodo.wi.mit.edu/primer3/).
To insert arms into the pAAV-LIC backbone, the pri-
mers needed to contain complementary sequences to
the ExoIII-generated overhangs in pAAV-LIC. The
designed and synthesized primers were Left Arm Sense
(50-ATG GTG AGA ATT TAT GAT-30), Left Arm Anti-
sense (50-TGG GAG GGT GGG GAT-30), Right Arm
Sense (50-ATG GGT GGT GGG AT-30), and Right Arm
Antisense (50-TTG GAA GTA TAA GAT-30).
Construction of the SirT1 AAV KO vector
Plasmid pAAV-LIC (2 μg) was subjected to overnight di-
gestion with EcoRV in a 50 μl reaction at 37°C. The two
fragments produced were purified using a gel extraction
kit and diluted to 50 ng/μl in TE buffer (pH8.0). Two
homologous arms were amplified from genomic DNA
extracted from HCT116 cells. Two pairs of unique pri-
mers were designed: (a) SirT1, left arm, forward (50-
ATGGTGAGAATTTATGATCGCCTGTTTGTATCCT-
TCCTGAC-30) and reverse (50-TGGGAGGGTGGG-
GATCAGAGATGGCTGGAATTGTCC–30); and (b)
SirT1, right arm, forward (50–ATGGGTGGTGGGAT-
CAGCCTTGTCAGATAAGGAAG–30) and reverse (50–
TTGGAAGTATAAGATCACCTTAGCTCGGCAGTTC
TT–30); (c) HDAC2, left arm, forward (50- ATGGTGA
GAATTTATGATAGCCAGCAGCATTGCTGCAG −30)
and reverse (50–TGGGAGGGTGGGGATAGCCGCG
GAACCCAGCGCC −30); and (d) HDAC2, right arm,
forward (50–ATGGGTGGTGGGATAAGTCTGCTAC
TACTACGAC −30) and reverse (50–TTGGAAGTATAA
GATCCCCAAAGCAGGGTCTAT −30). The underlined
sequences indicate the designed primers from the SirT1
genome DNA or HDAC2 genome DNA. The PCRs
were performed using pfu polymerase, with amplicons
electrophoresed and then recovered by gel extraction
kits. Recovered fragments were diluted to 100 ng/μl in
TE buffer.
The vector fragments and amplicons were mixed in
one reaction tube. The large fragment (1 μl), small frag-
ment (2 μl), left arm (2 μl) and right arm (2 μl) were
mixed with 1 μl of 10× ExoIII buffer and 1 μl of sterile
water. The tube was pre-chilled on ice for 2 min, and
then 1 μl of ExoIII (20 units) was added to the tube and
gently mixed. After a 1 h incubation at 0°C, 1 μl of 0.5
M EDTA was added to stop the reaction. The enzymewas inactivated at 65°C for 5 min. After cooling, the
mixture was transformed into E. coli DH5α and cultured
at 37°C overnight. Positive transformants were identified
by colony PCR and sequencing.
Somatic cell gene targeting
Somatic cell gene targeting was conducted as described
previously [5]. Briefly, the targeting AAVs were packaged
in 293T cells by transfecting equal amounts of SirT1 or
HDAC2 KO targeting vector, pHelper and pRC plasmids
(1 mg each). After 72 h, scraped the transfected cells
and suspended the cells into sterile phosphate-buffered
saline, then freezed and thawed the pellet three cycles,
finally spined the lysate to remove cell debris and
divided the supernatant containing rAAV into several
aliquots and frozen at-80°C. HCT116 or DLD1 cells
were infected with the SirT1 or HDAC2 targeting
viruses and selected with geneticin for two weeks. The
geneticin-resistant clones were then screened for hom-
ologous recombination by genomic PCR with primers
derived from the neomycin resistance gene (50-GTTG
TGCCCAGTCATAGCCG-30) and the upstream region
of the left homologous arm (SirT1: 50-GAAAGTTCCC
CACATCTGCT-30; HDAC2: 50-TGCTCCAATCTTC
CAGTGTCT-30). Positive clones were confirmed by gen-
omic PCR, with primers derived from the neomycin re-
sistance gene (50-TCTGGATTCATCGACTGTGG-30)
and the downstream region of the right homolo-
gous arm (SirT1: 50-TCACTCCTCCAGGGCTAAAA-30;
HDAC2 50-CACCTAGGAACAGCCTTTGC-30). Cor-
rectly targeted clones were infected with adenoviruses
expressing Cre-recombinase to delete the selectable drug
marker. To select clones with successful deletion of the
selectable drug marker, genomic PCR was employed to
amplify an approximate 250 bp fragment in which the




The heterozygous KO clones were infected with the
same targeting virus to target the second allele and the
neomycin resistance gene was excised as described earl-
ier. Final confirmation in the generation of the KO cell
lines was done using western blotting.
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